SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-016223
Filing Date
2018-01-22
Accepted
2018-01-22 17:18:22
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 d492423ds3a.htm S-3/A 190202
2 EX-23.1 d492423dex231.htm EX-23.1 2311
3 EX-23.3 d492423dex233.htm EX-23.3 2003
4 EX-23.4 d492423dex234.htm EX-23.4 1608
5 GRAPHIC g492423g25f42.jpg GRAPHIC 99938
6 GRAPHIC g492423g30a93.jpg GRAPHIC 79815
7 GRAPHIC g492423g43s46.jpg GRAPHIC 92710
8 GRAPHIC g492423g43t04.jpg GRAPHIC 104365
9 GRAPHIC g492423g57h77.jpg GRAPHIC 105547
  Complete submission text file 0001193125-18-016223.txt   862143
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-222487 | Film No.: 18540540
SIC: 2834 Pharmaceutical Preparations